Literature DB >> 22870853

Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Silvia Giatti1, Mariaserena Boraso, Federico Abbiati, Elisa Ballarini, Donato Calabrese, Maria Santos-Galindo, Roberta Rigolio, Marzia Pesaresi, Donatella Caruso, Barbara Viviani, Guido Cavaletti, Luis Miguel Garcia-Segura, Roberto Cosimo Melcangi.   

Abstract

Different experimental autoimmune encephalomyelitis models (EAE) have been developed. However, due to the different experimental conditions applied, observations simultaneously considering different pathological targets are still scarce. Using EAE induced in Dark Agouti rats with syngenic whole spinal cord homogenate suspended in incomplete Freund's adjuvant, we here analyze neurosteroidogenic machinery, cytokine levels, microglial cells, infiltration of inflammatory cells, myelin proteins and Na(+), K(+)-ATPase pump activity in the spinal cord. Data obtained in the acute phase of the disease confirmed that neurological signs were accompanied by the presence of perivascular infiltrating T cells (CD3(+) cells) and activated monocytic/microglial cells (ED1(+) and MHC-II(+)) in the spinal cord. In particular, the number of MHC-II(+) cells was significantly increased in association with increased expression of pro- (i.e., TNF-α, IL-1β) and anti-inflammatory (i.e., TGF-β) cytokines as well as with decreased expression of proteolipid protein and myelin basic protein. During the chronic phase of the disease, the number of MHC-II(+) cells was still increased, although less than in the acute phase. Changes in the number of MHC-II(+) cells were associated with decreased Na(+),K(+)-ATPase enzymatic activity. A general decrease in the levels of neuroactive steroids, with the exception of an increase in tetrahydroprogesterone and 17β-estradiol, was detected in the acute phase. These changes were maintained or reverted in the chronic phase of EAE. In conclusion, we report that modifications in the neuroimmune response in the acute and chronic phases of EAE are associated with specific changes in myelin proteins, Na(+),K(+)-ATPase pump and in the levels of neuroactive steroids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22870853     DOI: 10.1007/s11481-012-9385-9

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  52 in total

Review 1.  Blood-brain barrier disruption in multiple sclerosis.

Authors:  Alireza Minagar; J Steven Alexander
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

Review 2.  Neuroactive steroids: state of the art and new perspectives.

Authors:  R C Melcangi; L M Garcia-Segura; A G Mensah-Nyagan
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

3.  Symptoms of multiple sclerosis in women in relation to sex steroid exposure.

Authors:  Per Holmqvist; Malin Wallberg; Mats Hammar; A-M Landtblom; Jan Brynhildsen
Journal:  Maturitas       Date:  2005-11-15       Impact factor: 4.342

Review 4.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.

Authors:  E N Benveniste
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

5.  Activation of microglia in specific hypothalamic nuclei and the cerebellum of adult rats exposed to neonatal overnutrition.

Authors:  S Tapia-González; Lhav M García-Segura; M Tena-Sempere; L M Frago; J M Castellano; E Fuente-Martín; C García-Cáceres; J Argente; J A Chowen
Journal:  J Neuroendocrinol       Date:  2011-04       Impact factor: 3.627

6.  Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.

Authors:  P A McCombe; J Harness; M P Pender
Journal:  J Neuroimmunol       Date:  1999-06-01       Impact factor: 3.478

Review 7.  Steroids and glial cell function.

Authors:  Luis M Garcia-Segura; Roberto C Melcangi
Journal:  Glia       Date:  2006-11-01       Impact factor: 7.452

8.  Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease.

Authors:  L D Johns; S Sriram
Journal:  J Neuroimmunol       Date:  1993-08       Impact factor: 3.478

9.  Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury.

Authors:  I Roglio; R Bianchi; S Gotti; S Scurati; S Giatti; M Pesaresi; D Caruso; G C Panzica; R C Melcangi
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

10.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.

Authors:  J C Lorentzen; S Issazadeh; M Storch; M I Mustafa; H Lassman; C Linington; L Klareskog; T Olsson
Journal:  J Neuroimmunol       Date:  1995-12-31       Impact factor: 3.478

View more
  6 in total

Review 1.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

2.  The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundaries.

Authors:  Marco Cosentino; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2013-02-12       Impact factor: 4.147

Review 3.  Glial Na(+) -dependent ion transporters in pathophysiological conditions.

Authors:  Francesca Boscia; Gulnaz Begum; Giuseppe Pignataro; Rossana Sirabella; Ornella Cuomo; Antonella Casamassa; Dandan Sun; Lucio Annunziato
Journal:  Glia       Date:  2016-07-26       Impact factor: 7.452

4.  Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain.

Authors:  Andrew J Kwilasz; Suzanne M Green Fulgham; Julissa Chante Duran-Malle; Anouk E W Schrama; Eric H Mitten; Laurel S Todd; Hardik P Patel; Tracey A Larson; Madison A Clements; Kevin M Harris; Scott T Litwiler; Lewis O Harvey; Steven F Maier; Raymond A Chavez; Kenner C Rice; Anne-Marie Van Dam; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2021-01-07       Impact factor: 7.217

5.  Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling.

Authors:  Stefano Tambalo; Luca Peruzzotti-Jametti; Roberta Rigolio; Silvia Fiorini; Pietro Bontempi; Giulia Mallucci; Beatrice Balzarotti; Paola Marmiroli; Andrea Sbarbati; Guido Cavaletti; Stefano Pluchino; Pasquina Marzola
Journal:  J Neurosci       Date:  2015-07-08       Impact factor: 6.167

Review 6.  Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.